Pre-malignancies in Hematology episode artwork

EPISODE · Mar 20, 2026 · 57 MIN

Pre-malignancies in Hematology

from OSU MedNet21

This program will discuss Pre-malignancies in Hematology. This presentation reviews the spectrum of premalignant hematologic disorders including clonal hematopoiesis, B cell disorders, and plasma cell disorders. First, the presentation will review clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance. The second part of the talk will go over monoclonal B lymphocytosis. The last portion will cover monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Learners will review diagnostic criteria, risk stratification models, and clinical monitoring strategies for these conditions. The session will emphasize practical approaches to evaluation, risk assessment, and management decisions in patients with hematologic malignancy precursor conditions. Link to transcript [Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/03/Pre-malignanciesinHematology_transcript.pdf)

Episode metadata supplied by the publisher feed · Published Mar 20, 2026

Embed this episode

NOW PLAYING

Pre-malignancies in Hematology

0:00 57:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of OSU MedNet21?

This episode is 57 minutes long.

When was this OSU MedNet21 episode published?

This episode was published on March 20, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this OSU MedNet21 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!